- Home
- RGR vs BCYC Comparison
RGR vs BCYC Comparison
Compare RGR & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGR
- BCYC
- Stock Information
- Founded
- RGR 1949
- BCYC 2009
- Country
- RGR United States
- BCYC United Kingdom
- Employees
- RGR N/A
- BCYC N/A
- Industry
- RGR Ordnance And Accessories
- BCYC Biotechnology: Pharmaceutical Preparations
- Sector
- RGR Industrials
- BCYC Health Care
- Exchange
- RGR Nasdaq
- BCYC Nasdaq
- Market Cap
- RGR 664.0M
- BCYC 581.7M
- IPO Year
- RGR N/A
- BCYC 2019
- Fundamental
- Price
- RGR $35.31
- BCYC $8.27
- Analyst Decision
- RGR
- BCYC Buy
- Analyst Count
- RGR 0
- BCYC 10
- Target Price
- RGR N/A
- BCYC $25.00
- AVG Volume (30 Days)
- RGR 183.9K
- BCYC 370.6K
- Earning Date
- RGR 04-30-2025
- BCYC 05-01-2025
- Dividend Yield
- RGR 2.00%
- BCYC N/A
- EPS Growth
- RGR N/A
- BCYC N/A
- EPS
- RGR 1.83
- BCYC N/A
- Revenue
- RGR $534,561,000.00
- BCYC $25,722,000.00
- Revenue This Year
- RGR $4.74
- BCYC N/A
- Revenue Next Year
- RGR N/A
- BCYC $0.27
- P/E Ratio
- RGR $19.14
- BCYC N/A
- Revenue Growth
- RGR 0.65
- BCYC N/A
- 52 Week Low
- RGR $34.11
- BCYC $6.10
- 52 Week High
- RGR $47.27
- BCYC $28.67
- Technical
- Relative Strength Index (RSI)
- RGR 40.06
- BCYC 48.36
- Support Level
- RGR $32.74
- BCYC $7.95
- Resistance Level
- RGR $40.91
- BCYC $9.55
- Average True Range (ATR)
- RGR 1.27
- BCYC 0.73
- MACD
- RGR -0.61
- BCYC 0.05
- Stochastic Oscillator
- RGR 31.82
- BCYC 38.84
About RGR Sturm Ruger & Company Inc.
Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.